title: Congestive heart failure disease management program: 1-Year population experience from a tertiary center heart failure registry in Saudi Arabia.
abstract: OBJECTIVE
  We aimed to evaluate congestive heart failure (CHF) multidisciplinary disease management program (DMProg) impact on mortality, readmission rates, length of stay (LOS), and gender health characteristics.
  
  
  RESULTS
  This was a quasi-observational, pre- and post-trial with a parallel nonequivalent group. We enrolled 174 inpatients having CHF with reduced ejection fraction and New York Heart Association (NYHA) Class II-IV, and a total of 197 hospital admissions. A comparative follow-up was performed from 15 December 2014 to 15 December 2015. Among 197 consecutive hospital admissions, 76 (39%) were included in the preintervention or usual care group and 121 (61%) were assigned to the postintervention group. After 1 year, in comparison with the preintervention group, the postintervention group had shorter average LOS in days (7.6 days vs. 11.1 days,p< 0.002), lower 1-year readmission rate (36% vs. 57%,p< 0.003), and lower in-house mortality (1.6% vs. 7.8%,p= 0.03), but similar baseline mortality scores (38.2 vs. 38.6,p= 0.7), 30-day and 90-day readmission rates (15% vs. 18.3%,p= 0.62 and 27.6% vs. 30%,p= 0.65), and 30-day readmission risk score (24.9% vs. 26.2%,p= 0.09). By regression analysis, the DMProg intervention was an independent factor for 1-year readmission reduction (p= 0.001). Kaplan-Meier survival analysis favored the postintervention group (log-rank,p< 0.001).
  
  
  CONCLUSIONS
  DMProg significantly decreased 1-year readmission rates, LOS, and in-house mortality.
authors.affiliation: Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
authors.forename: Khal
authors.initials: K
authors.lastname: Salem
authors.affiliation: Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
authors.forename: Dania
authors.initials: D
authors.lastname: Fallata
authors.affiliation: Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia; Zagazig University, Cairo, bEgypt.
authors.forename: Maha
authors.initials: M
authors.lastname: ElSebaie
authors.affiliation: Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
authors.forename: Ahmad
authors.initials: A
authors.lastname: Montasser
authors.affiliation: Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
authors.forename: Khaled
authors.initials: K
authors.lastname: ElGedamy
authors.affiliation: Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
authors.forename: Osama
authors.initials: O
authors.lastname: ElKhateeb
keywords: Disease management program; Heart failure; Middle East; Saudi Arabia